Norethisterone Acetate

Specifications

51-98-9CAS Number

200-132-0EC Number

[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetateIUPAC Name

C22H28O3Chemical Formula

340.5 g/molMolecular Weight

Norethindrone acetate; Norethisterone acetate; 51-98-9; 19-Norethindrone acetate; Norlutin acetate; ENTA; Norethisteron acetate; 19-Norethisterone acetate; Norethindrone 17-acetate; 19-Norethynyltestosterone acetate; (17-alpha)-Norethindrone acetate; Norethynyltestosterone; 17alpha-Ethynyl-19-nortestosterone acetate; DTXSID4023381; Norethisterone 17-acetate; 17-alpha-Ethinyl-19-nortestosterone acetate; 17-alpha-Ethynyl-19-nortestosterone acetate; 9S44LIC7OJ; Norethindrone acetate [USP]; NSC-22844; SH-420; Norethisteroni acetas; 17alpha-Ethinyl-19-nortestosterone 17beta-acetate; 17alpha-Ethinyl-19-nortestosterone-17beta-acetate; 17alpha-Ethynyl-17-hydroxyestr-4-en-3-one acetate; 17-alpha-Ethinyl-19-nortestosterone-17-beta-acetate; 17-alpha-Ethynyl-17-hydroxyestr-4-en-3-one acetate; 17-Acetoxy-19-nor-17alpha-pregn-4-en-20-yn-3-one; 17-Acetoxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one; 17alpha-Ethynyl-17beta-acetoxy-19-norandrost-4-en-3-one; 17beta-Acetoxy-19-nor-17alpha-pregn-4-en-20-yn-3-one; [(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate; 17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one acetate; 17beta-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one acetate; Norethindrone acetate (USP); 17-Acetyloxy(17-alpha)-19-norpregn-4-estren-17-beta-ol-acetate-3-one; CHEBI:7628; DTXCID601071; FEMLYV COMPONENT NORETHINDRONE ACETATE; ORIAHNN COMPONENT NORETHINDRONE ACETATE; MYFEMBREE COMPONENT NORETHINDRONE ACETATE; Gallifrey; Ortho Micronor; ((8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta(a)phenanthren-17-yl) acetate; Norethidrone Acetate; RefChem:55726; Estr-4-en-3-one, 17-(acetyloxy)-17-ethynyl-, (17beta)-; 200-132-0; NSC9564; Norlutate; Orlutate; Primolut-Nor; Aygestin; Norethysterone acetate; Norethynyltestosterone acetate; Norlutin A; Norlutine acetate; SH 420; Milligynon; Miniphase; Progylut; 17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one acetate; Milli-Anovlar; MFCD00271615; Norlutin-A; (17alpha)-17-(Acetyloxy)-19-Norpregn-4-en-20-yn-3-one; Gestakadin; Monogest; NSC 22844; 17.alpha.-Ethynyl-19-nortestosterone acetate; Norethisterone acetate (JAN); NORETHISTERONE ACETATE [JAN]; (1S,11S,15S,2R,10R,14R)-14-ethynyl-15-methyl-5-oxotetracyclo[8.7.0.0<2,7>.0<11 ,15>]heptadec-6-en-14-yl acetate; CCRIS 485; Ethinyl-nortestosterone acetate; EINECS 200-132-0; UNII-9S44LIC7OJ; BRN 2064104; SH-420C; NCGC00183366-01; Aygestin (TN); norethindrone-acetate; 17.alpha.-Ethinyl-19-nortestosterone acetate; 19-nor-17alpha-Pregn-4-en-20-yn-3-one, 17-acetoxy-; Estr-4-en-3-one, 17alpha-ethynyl-17-hydroxy-, acetate; (17-alpha)-17-(Acetyloxy)-19-norpregn-4-en-20-yn-3-one; 17-alpha-Ethynyl-17-beta-acetoxy-19-norandrost-4-en-3-one; 19-Nor-17alpha-ethynyltestosterone Acetate; Norethisterone acetate RS; Norethisterone acetate CRS; Norethisterone acetate (Norethindrone acetate); 17-Acetoxy-19-nor-17.alpha.-pregn-4-en-20-yn-3-one; 17.alpha.-Ethinyl-19-nortestosterone 17.beta.-acetate; 19-nor-17.alpha.-Pregn-4-en-20-yn-3-one, 17-acetoxy-; SCHEMBL37530; 17-Hydroxy-19-nor-17.alpha.-pregn-4-en-20-yn-3-one acetate; 17.beta.-Acetoxy-19-nor-17.alpha.-pregn-4-en-20-yn-3-one; (17beta)-17-ethynyl-3-oxoestr-4-en-17-yl acetate; orb1690485; orb3139940; 17-Acetyloxy(17.alpha.)-19-norpregn-4-estren-17.beta.-ol-acetate-3-one; 17.beta.-Hydroxy-19-nor-17.alpha.-pregn-4-en-20-yn-3-one acetate; CHEMBL1201146; Norethindrone acetate (Standard); HY-B1710R; 19-Nor-17-alpha-pregn-4-en-20-yn-3-one, 17-acetoxy-; MSK2204; WLZ4548; HMS3259A16; NORETHINDRONE ACETATE [MI]; 19-Nor-17alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-, acetate; 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha); HY-B1710; NSC22844; Tox21_113371; MSK2204-100M; NORETHINDRONE ACETATE [VANDF]; s5785; AKOS016010517; MSK2204-1000M; NORETHINDRONE ACETATE [USP-RS]; NORETHISTERONE ACETATE [MART.]; CS-7730; FN26444; NC00575; NORETHISTERONE ACETATE [WHO-DD]; NORETHISTERONE ACETATE [WHO-IP]; 17?-Ethynyl-19-nortestosterone acetate; CAS-51-98-9; NCGC00159500-02; NCGC00183366-07; AS-13383; CPD001906776; ST075199; SY076006; NORETHINDRONE ACETATE [ORANGE BOOK]; FEMHRT COMPONENT NORETHINDRONE ACETATE; N0450; NORETHINDRONE ACETATE [USP MONOGRAPH]; NORETHISTERONE ACETATE [EP MONOGRAPH]; NORETHISTERONI ACETAS [WHO-IP LATIN]; ACTIVELLA COMPONENT NORETHINDRONE ACETATE; C08152; D00953; T40598; COMBIPATCH COMPONENT NORETHINDRONE ACETATE; Norethisterone acetate for system suitability CRS; ESTROSTEP FE COMPONENT NORETHINDRONE ACETATE; F242197; TRI-LEGEST FE COMPONENT NORETHINDRONE ACETATE; 17.alpha.-Ethynyl-17-hydroxyestr-4-en-3-one acetate; 19-Nor-17.alpha.-pregn-4-en-20-yn-3-one, acetate; BRD-K96037667-001-01-4; LO LOESTRIN FE COMPONENT NORETHINDRONE ACETATE; Norethisterone acetate Solution in Methanol, 100ug/mL; Q47495694; 17.alpha.-Ethinyl-19-nortestosterone-17.beta.-acetate; 3-Oxo-17alpha-19-norpregn-4-en-20-yn-17-yl acetate; Norethisterone acetate Solution in Methanol, 1000ug/mL; WLN: L E5 B666 OV MUTJ E FOV1 F1UU1 -B&EF; (17?)-17-(Acetyloxy)-19-norpregn-4-en-20-yn-3-one; (17|_)-17-(Acetyloxy)-19-norpregn-4-en-20-yn-3-one; (17alpha)-3-oxo-19-norpregn-4-en-20-yn-17-yl acetate; 17.alpha.-Ethynyl-17.beta.-acetoxy-19-norandrost-4-en-3-one; 19-Norethindrone acetate, VETRANAL(TM), analytical standard; Norethindrone acetate, United States Pharmacopeia (USP) Reference Standard; Norethisterone acetate, European Pharmacopoeia (EP) Reference Standard; Norethisterone acetate for system suitability, European Pharmacopoeia (EP) Reference Standard; (8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetateSynonyms